NCT05259709 2025-09-11A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With CemiplimabRegeneron PharmaceuticalsPhase 1 Recruiting50 enrolled